Orbimed Advisors LLC Kezar Life Sciences, Inc. Transaction History
Orbimed Advisors LLC
- $4.44 Billion
- Q1 2024
A detailed history of Orbimed Advisors LLC transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 1,927,000 shares of KZR stock, worth $1.1 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,927,000
Previous 1,927,000
-0.0%
Holding current value
$1.1 Million
Previous $1.83 Million
5.25%
% of portfolio
0.04%
Previous 0.04%
Shares
8 transactions
Others Institutions Holding KZR
# of Institutions
86Shares Held
45MCall Options Held
2.6KPut Options Held
600-
Suvretta Capital Management, LLC New York, NY7.17MShares$4.09 Million0.28% of portfolio
-
Avidity Partners Management LP Dallas, TX5.03MShares$2.86 Million0.17% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$2.63 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.09MShares$1.76 Million0.0% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L32.05MShares$1.17 Million0.29% of portfolio
About Kezar Life Sciences, Inc.
- Ticker KZR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,369,504
- Market Cap $39M
- Description
- Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...